ArticleBlood research2025

Early CD4 + T cell immune reconstitution as a biomarker for Epstein-Barr virus control following allogeneic transplantation.

Kexin Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.